BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schlicker E, Kathmann M. Presynaptic Neuropeptide Receptors. In: Südhof TC, Starke K, editors. Pharmacology of Neurotransmitter Release. Berlin: Springer Berlin Heidelberg; 2008. pp. 409-34. [DOI: 10.1007/978-3-540-74805-2_13] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Klisch C, Inyushkin A, Mordel J, Karnas D, Pévet P, Meissl H. Orexin A modulates neuronal activity of the rodent suprachiasmatic nucleus in vitro. European Journal of Neuroscience 2009;30:65-75. [DOI: 10.1111/j.1460-9568.2009.06794.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 2.5] [Reference Citation Analysis]
2 Parmentier R, Kolbaev S, Klyuch BP, Vandael D, Lin JS, Selbach O, Haas HL, Sergeeva OA. Excitation of histaminergic tuberomamillary neurons by thyrotropin-releasing hormone. J Neurosci 2009;29:4471-83. [PMID: 19357273 DOI: 10.1523/JNEUROSCI.2976-08.2009] [Cited by in Crossref: 41] [Cited by in F6Publishing: 22] [Article Influence: 3.2] [Reference Citation Analysis]
3 Domin H. Neuropeptide Y Y2 and Y5 receptors as potential targets for neuroprotective and antidepressant therapies: Evidence from preclinical studies. Prog Neuropsychopharmacol Biol Psychiatry 2021;111:110349. [PMID: 33991587 DOI: 10.1016/j.pnpbp.2021.110349] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Schlicker E, Feuerstein T. Human presynaptic receptors. Pharmacol Ther 2017;172:1-21. [PMID: 27902931 DOI: 10.1016/j.pharmthera.2016.11.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
5 Regehr WG, Carey MR, Best AR. Activity-dependent regulation of synapses by retrograde messengers. Neuron 2009;63:154-70. [PMID: 19640475 DOI: 10.1016/j.neuron.2009.06.021] [Cited by in Crossref: 157] [Cited by in F6Publishing: 163] [Article Influence: 12.1] [Reference Citation Analysis]
6 Li S, Franken P, Vassalli A. Bidirectional and context-dependent changes in theta and gamma oscillatory brain activity in noradrenergic cell-specific Hypocretin/Orexin receptor 1-KO mice. Sci Rep 2018;8:15474. [PMID: 30341359 DOI: 10.1038/s41598-018-33069-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
7 Vidal-Torres A, Fernández-Pastor B, Carceller A, Vela JM, Merlos M, Zamanillo D. Effects of the selective sigma-1 receptor antagonist S1RA on formalin-induced pain behavior and neurotransmitter release in the spinal cord in rats. J Neurochem 2014;129:484-94. [PMID: 24384038 DOI: 10.1111/jnc.12648] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
8 Nozdrachev AD, Masliukov PM. Neuropeptide Y and autonomic nervous system. J Evol Biochem Phys 2011;47:121-30. [DOI: 10.1134/s0022093011020010] [Cited by in Crossref: 7] [Article Influence: 0.6] [Reference Citation Analysis]
9 Plaza-Zabala A, Maldonado R, Berrendero F. The hypocretin/orexin system: implications for drug reward and relapse. Mol Neurobiol 2012;45:424-39. [PMID: 22430644 DOI: 10.1007/s12035-012-8255-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 3.5] [Reference Citation Analysis]
10 Heinke B, Gingl E, Sandkühler J. Multiple targets of μ-opioid receptor-mediated presynaptic inhibition at primary afferent Aδ- and C-fibers. J Neurosci 2011;31:1313-22. [PMID: 21273416 DOI: 10.1523/JNEUROSCI.4060-10.2011] [Cited by in Crossref: 95] [Cited by in F6Publishing: 57] [Article Influence: 8.6] [Reference Citation Analysis]
11 Wehrwein EA, Orer HS, Barman SM. Overview of the Anatomy, Physiology, and Pharmacology of the Autonomic Nervous System. Compr Physiol. 2016;6:1239-1278. [PMID: 27347892 DOI: 10.1002/cphy.c150037] [Cited by in Crossref: 106] [Cited by in F6Publishing: 88] [Article Influence: 17.7] [Reference Citation Analysis]